Are there specific concerns about dextroamphetamine, mixed amphetamine salts and lisdexamfetamine use in pregnancy?
If you are planning on becoming pregnant, inform your healthcare provider immediately so that your healthcare provider can best manage your medications. Amphetamine and dextroamphetamine have been shown to cause fetal malformation and death in mice when administered at a higher dose than that of human dose. One report shows severe congenital deformity in a baby born to a woman who took dextroamphetamine (and other medication) during the first trimester of pregnancy. Infants born to mothers dependent on dextroamphetamine, mixed amphetamine salts or lisdexamfetamine have an increased risk of premature delivery and low birth weight. These infants may also experience symptoms of withdrawal such as agitation or lack of energy. Several case reports show that amphetamine use during pregnancy significantly influences development of exposed children up to at least 10 years old with an increase in aggressive behavior. Mothers taking dextroamphetamine, mixed amphetamine salts and lisdexamfetamine
